NO993467D0 - Granuler som innbefatter klavulanat og en eller flere eksipienter - Google Patents

Granuler som innbefatter klavulanat og en eller flere eksipienter

Info

Publication number
NO993467D0
NO993467D0 NO993467A NO993467A NO993467D0 NO 993467 D0 NO993467 D0 NO 993467D0 NO 993467 A NO993467 A NO 993467A NO 993467 A NO993467 A NO 993467A NO 993467 D0 NO993467 D0 NO 993467D0
Authority
NO
Norway
Prior art keywords
clavulanate
excipients
granules
Prior art date
Application number
NO993467A
Other languages
English (en)
Norwegian (no)
Other versions
NO993467L (no
Inventor
Jan Willem Groenendaal
Original Assignee
Gist Brocades Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Bv filed Critical Gist Brocades Bv
Publication of NO993467L publication Critical patent/NO993467L/no
Publication of NO993467D0 publication Critical patent/NO993467D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO993467A 1997-11-17 1999-07-14 Granuler som innbefatter klavulanat og en eller flere eksipienter NO993467D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203576 1997-11-17
PCT/EP1998/007225 WO1999025343A1 (fr) 1997-11-17 1998-11-09 Granules comprenant du clavulanate et un ou plusieurs excipients

Publications (2)

Publication Number Publication Date
NO993467L NO993467L (no) 1999-07-14
NO993467D0 true NO993467D0 (no) 1999-07-14

Family

ID=8228930

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993467A NO993467D0 (no) 1997-11-17 1999-07-14 Granuler som innbefatter klavulanat og en eller flere eksipienter

Country Status (13)

Country Link
EP (1) EP0973520A1 (fr)
JP (1) JP2001516365A (fr)
CN (1) CN1242705A (fr)
AU (1) AU1337999A (fr)
BR (1) BR9806280A (fr)
CA (1) CA2272402A1 (fr)
CO (1) CO4980893A1 (fr)
JO (1) JO2082B1 (fr)
NO (1) NO993467D0 (fr)
PL (1) PL334517A1 (fr)
TR (1) TR199901584T1 (fr)
WO (1) WO1999025343A1 (fr)
ZA (1) ZA9810499B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (fr) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
GB0031267D0 (en) * 2000-12-21 2001-01-31 Smithkline Beecham Plc Novel compositions
AT413983B (de) * 2001-04-12 2006-08-15 Sandoz Ag K-clavulanat in der form eines granulates
AT412344B (de) * 2001-04-12 2005-01-25 Sandoz Ag Hydrophobisierte teilchen von k-clavulanat
US8293272B2 (en) * 2003-05-02 2012-10-23 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
WO2004096177A1 (fr) * 2003-05-02 2004-11-11 Globopharm Pharmazeutische Produktions- Und Handelsgesellschaft M.B.H. Preparation pharmaceutique solide contenant des sels de levothyroxine et/ou de liothyronine
FI20080351A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi
FI20080352A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi korkean lääkepitoisuuden tabletin valmistamiseksi
FI20070521A7 (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
FI20080353A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi erittäin korkean lääkepitoisuuden tabletin valmistamiseksi
FI20080346A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi lisäaineita sisältävän tabletin valmistamiseksi
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080355A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi metforminia käsittävien tablettien valmistamiseksi
WO2009135946A1 (fr) 2008-05-09 2009-11-12 Atacama Labs Oy Procédé et appareil de granulation par voie sèche
US20150238425A1 (en) * 2012-08-28 2015-08-27 Dsm Sinochem Pharmaceuticals Netherlands B.V. Mini-tablets
JP2014062064A (ja) * 2012-09-21 2014-04-10 Ohara Yakuhin Kogyo Kk バルサルタン含有錠剤の製造方法
JP6141472B2 (ja) * 2016-03-02 2017-06-07 大原薬品工業株式会社 バルサルタン含有錠剤の製造方法
JP2019529343A (ja) * 2017-07-05 2019-10-17 ノバルティス アーゲー 新規な医薬組成物
CN110051637A (zh) * 2019-05-21 2019-07-26 葵花药业集团北京药物研究院有限公司 阿莫西林克拉维酸钾制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2251250C3 (de) * 1972-10-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten
NZ187013A (en) * 1977-04-27 1985-04-30 Beecham Group Ltd 9-amino-9-deoxy-clavulanic acid derivatives and pharmaceutical compositions
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby

Also Published As

Publication number Publication date
CN1242705A (zh) 2000-01-26
JO2082B1 (en) 2000-05-21
EP0973520A1 (fr) 2000-01-26
PL334517A1 (en) 2000-02-28
WO1999025343A1 (fr) 1999-05-27
ZA9810499B (en) 1999-05-24
JP2001516365A (ja) 2001-09-25
BR9806280A (pt) 2000-02-15
AU1337999A (en) 1999-06-07
CO4980893A1 (es) 2000-11-27
CA2272402A1 (fr) 1999-05-27
NO993467L (no) 1999-07-14
TR199901584T1 (xx) 2000-01-21

Similar Documents

Publication Publication Date Title
NO993467D0 (no) Granuler som innbefatter klavulanat og en eller flere eksipienter
DK1015434T3 (da) Ny pyrimidin-4-on og pyrimidin-4-thion som fungicid
DK0906292T3 (da) Triazolylmercaptider og deres anvendelse som mikrobicider
DK0815861T3 (da) Sulfonamider og anvendelse deraf
DK0915880T3 (da) Azolotriaziner og pyrimidiner
NO990965D0 (no) Terapeutiske fremgangsmÕter og blandinger som inneholder isoflavoner
NO991922D0 (no) Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer
DE69836432D1 (de) Bildcoder und -decoder
NO993887D0 (no) Farmasöytiske formuleringer som innbefatter amoksycillin og clavulanat
NO993868D0 (no) 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike
NO971811D0 (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
DK0906301T3 (da) Benzofurylderivater og anvendelsen deraf
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
NO20000366D0 (no) O-substituerte hydroksycoumaranon-derivater som anti-tumor- og antimetastase-midler
NO984761D0 (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
TR199800117A3 (tr) Isaksazol- ve krotonasitamid türevleri ve bunlarin kullanimi.
NO995683D0 (no) Vitamin D analoger og deres neuronale effekter
NO981282D0 (no) Calcitriolderivater og deres anvendelser
NO985891D0 (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
EE9900331A (et) Tahked segud sulfonüülkarbamiidide ja adjuvantide baasil
NO984444L (no) Benzothiofener, formuleringer som inneholder de samme og fremgangsmÕter
NO983802D0 (no) Benzothiofener, formuleringer inneholdende samme og fremgangsmÕter
NO308213B1 (no) Substituerte indanylidinacetylguanidiner, deres anvendelse og medikamenter inneholdende forbindelsene
NO972256D0 (no) O-Benzyloksimeterderivater og deres anvendelse som pesticider

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application